This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Dec;23(12):906-23.

doi: 10.3760/cma.j.issn.1007-3418.2015.12.003.

[The guideline of prevention and treatment for hepatitis C: a 2015 update]

[Article in Chinese]

Chinese Society of Hepatology, Chinese Medical Association; Lai Wei¹; Chinese Society of Infectious Diseases, Chinese Medical Association; Jin-Lin Hou²

Affiliations

Affiliations

¹ Peking University People's Hospital, Peking University Hepatology Institute, Beijing 100044, China.
² Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.

PMID: 26739465
DOI: 10.3760/cma.j.issn.1007-3418.2015.12.003

[The guideline of prevention and treatment for hepatitis C: a 2015 update]

[Article in Chinese]

Chinese Society of Hepatology, Chinese Medical Association et al. Zhonghua Gan Zang Bing Za Zhi. 2015 Dec.

. 2015 Dec;23(12):906-23.

doi: 10.3760/cma.j.issn.1007-3418.2015.12.003.

Authors

Chinese Society of Hepatology, Chinese Medical Association; Lai Wei¹; Chinese Society of Infectious Diseases, Chinese Medical Association; Jin-Lin Hou²

Affiliations

¹ Peking University People's Hospital, Peking University Hepatology Institute, Beijing 100044, China.
² Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.

PMID: 26739465
DOI: 10.3760/cma.j.issn.1007-3418.2015.12.003

No abstract available

PubMed Disclaimer

Similar articles

[Guidelines for the prevention and treatment of hepatitis C (2019 version)].
Chinese Society of Hepatology; Chinese Society of Infectious Diseases, Chinese Medical Association. Chinese Society of Hepatology, et al. Zhonghua Gan Zang Bing Za Zhi. 2019 Dec 20;27(12):962-979. doi: 10.3760/cma.j.issn.1007-3418.2019.12.008. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 31941258 Chinese.
HEP DART 2005 -- HCV therapeutics.
Inchauspe G. Inchauspe G. IDrugs. 2006 Mar;9(3):168-70. IDrugs. 2006. PMID: 16523377 No abstract available.
Toward evidence based control of hepatitis C virus infection.
Miyamura T. Miyamura T. Adv Drug Deliv Rev. 2007 Oct 10;59(12):1195. doi: 10.1016/j.addr.2007.08.002. Epub 2007 Aug 11. Adv Drug Deliv Rev. 2007. PMID: 17889399 No abstract available.
[Current Guidelines for treatment of hepatitis C. The eradication of HCV as a goal].
Sarrazin C, Zeuzem S. Sarrazin C, et al. Pharm Unserer Zeit. 2011 Jan;40(1):52-9. doi: 10.1002/pauz.201100400. Pharm Unserer Zeit. 2011. PMID: 21194083 Review. German. No abstract available.
[Guidelines for treatment of hepatitis C].
Iino S. Iino S. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):342-6. Nihon Rinsho. 2004. PMID: 15359818 Review. Japanese. No abstract available.

See all similar articles

Cited by

Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients.
Ji D, Chen GF, Wang C, Wang YD, Shao Q, Li B, Zhao J, You SL, Hu JH, Liu JL, Niu XX, Chen J, Lu L, Wu V, Lau G. Ji D, et al. Hepatol Int. 2016 Sep;10(5):789-98. doi: 10.1007/s12072-016-9755-0. Epub 2016 Jul 21. Hepatol Int. 2016. PMID: 27443347
Plasma Golgi protein 73 levels predict prognosis of HCV-related hepatic fibrosis.
Liu L, Al-Dhamin Z, Yuan X, Cui L, Yang Y, Zhao W, Zhang Y, Fu N, Nan Y. Liu L, et al. Histol Histopathol. 2020 Nov;35(11):1309-1318. doi: 10.14670/HH-18-269. Epub 2020 Oct 14. Histol Histopathol. 2020. PMID: 33063838
Prevalence, diagnosis, and treatment of hepatitis C in Mainland China.
Mei X, Lu H. Mei X, et al. Glob Health Med. 2021 Oct 31;3(5):270-275. doi: 10.35772/ghm.2021.01080. Glob Health Med. 2021. PMID: 34782868 Free PMC article. Review.
SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.
Li Y, Wang J, Wang J, Xiao Y, Xu B, Li H, Yang L, Hao X, Ma Y. Li Y, et al. Virol J. 2017 Mar 23;14(1):62. doi: 10.1186/s12985-017-0708-6. Virol J. 2017. PMID: 28335783 Free PMC article.
Economic Evaluation of Hepatitis C Treatment Extension to Acute Infection and Early-Stage Fibrosis Among Patients Who Inject Drugs in Developing Countries: A Case of China.
Liu Y, Zhang H, Zhang L, Zou X, Ling L. Liu Y, et al. Int J Environ Res Public Health. 2020 Jan 28;17(3):800. doi: 10.3390/ijerph17030800. Int J Environ Res Public Health. 2020. PMID: 32012839 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Chinese Medical Association Publishing House Ltd.
Medical
- MedlinePlus Health Information